$15.64
0.64% yesterday
Nasdaq, Aug 21, 10:00 pm CET
ISIN
US8257041090
Symbol
SIBN

SI-BONE, Inc. Stock price

$15.64
-1.03 6.18% 1M
-2.20 12.33% 6M
+1.62 11.55% YTD
+0.55 3.64% 1Y
-1.67 9.65% 3Y
-4.92 23.93% 5Y
-4.42 22.03% 10Y
-4.42 22.03% 20Y
Nasdaq, Closing price Thu, Aug 21 2025
+0.10 0.64%

Key metrics

Basic
Market capitalization
$670.4m
Enterprise Value
$560.4m
Net debt
positive
Cash
$145.5m
Shares outstanding
43.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
3.6 | 3.4
EV/Sales
3.0 | 2.8
EV/FCF
negative
P/B
3.9
Financial Health
Equity Ratio
72.5%
Return on Equity
-18.5%
ROCE
-13.4%
ROIC
-35.9%
Debt/Equity
0.2
Financials (TTM | estimate)
Revenue
$185.3m | $199.8m
EBITDA
$-22.7m | $-262.3k
EBIT
$-27.6m | $-30.5m
Net Income
$-23.8m | $-27.8m
Free Cash Flow
$-12.7m
Growth (TTM | estimate)
Revenue
22.9% | 19.5%
EBITDA
44.2% | 99.2%
EBIT
39.7% | 13.4%
Net Income
41.8% | 10.1%
Free Cash Flow
51.0%
Margin (TTM | estimate)
Gross
79.5%
EBITDA
-12.2% | -0.1%
EBIT
-14.9%
Net
-12.8% | -13.9%
Free Cash Flow
-6.9%
More
EPS
$-0.6
FCF per Share
$-0.3
Short interest
4.5%
Employees
349
Rev per Employee
$480.0k
Show more

Is SI-BONE, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,014 stocks worldwide.

SI-BONE, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a SI-BONE, Inc. forecast:

14x Buy
93%
1x Hold
7%

Analyst Opinions

15 Analysts have issued a SI-BONE, Inc. forecast:

Buy
93%
Hold
7%

Financial data from SI-BONE, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
185 185
23% 23%
100%
- Direct Costs 38 38
13% 13%
21%
147 147
26% 26%
79%
- Selling and Administrative Expenses 158 158
8% 8%
85%
- Research and Development Expense 17 17
0% 0%
9%
-23 -23
44% 44%
-12%
- Depreciation and Amortization 4.94 4.94
5% 5%
3%
EBIT (Operating Income) EBIT -28 -28
40% 40%
-15%
Net Profit -24 -24
42% 42%
-13%

In millions USD.

Don't miss a Thing! We will send you all news about SI-BONE, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

SI-BONE, Inc. Stock News

Positive
The Motley Fool
17 days ago
Si-bone (SIBN 2.93%), a medical device innovator focused on minimally invasive surgery for joint dysfunction and pelvic conditions, released its second quarter 2025 results on August 4, 2025. The company reported GAAP revenue of $48.6 million and a GAAP net loss per share of $(0.14) for Q2 2025.
Neutral
Seeking Alpha
17 days ago
SI-BONE, Inc. (NASDAQ:SIBN ) Q2 2025 Earnings Conference Call August 4, 2025 4:30 PM ET Company Participants Anshul Maheshwari - Chief Financial Officer Laura A. Francis - CEO & Director Saqib Iqbal - Director of FP&A and Investor Relations Conference Call Participants Caitlin Cronin - Canaccord Genuity Corp., Research Division Craig William Bijou - BofA Securities, Research Division David Josh...
Neutral
GlobeNewsWire
17 days ago
Achieved ~22% worldwide revenue growth, positive Adjusted EBITDA and cash flow breakeven Achieved ~22% worldwide revenue growth, positive Adjusted EBITDA and cash flow breakeven
More SI-BONE, Inc. News

Company Profile

SI-BONE, Inc. is a medical device company. It focuses on the development of implantable devices used in the surgical treatment of the sacropelvic anatomy. The firm's product, iFuse, seeks to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in San Jose, CA.

Head office United States
CEO Laura Francis
Employees 349
Founded 2008
Website si-bone.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today